Ipsos (IPS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Dec, 2025Executive summary
Q1 2025 revenue reached €568.5m, up 2.0% year-over-year, with -1.8% organic growth offset by scope and FX effects, mainly from acquisitions and currency movements before tariff announcements.
Results aligned with expectations amid heightened market volatility, with leadership emphasizing resilience and ongoing transformation initiatives.
Major acquisition of BVA underway, consolidating leadership in France and expanding capabilities in customer experience, luxury, and behavioral sciences.
AI deployment is now routine, with 75% of staff AI certified and significant productivity gains realized through synthetic data and automation.
Financial highlights
Q1 2025 revenue: €568.5m, up 2.0% year-over-year; organic growth -1.8%, scope effect 2.9%, currency impact 0.9%.
EMEA region grew 6.1% (mainly from Infas integration), Americas flat or down 1.7%, Asia-Pacific declined 4.7% due to China and India slowdowns.
Doctors and patients segment grew 6.9% (total), 5.4% organic; citizens' business declined 14.2% organic, sharply impacted by political instability and electoral cycles.
Ipsos Digital DIY platform grew ~30% organically in Q1, targeting €140 million in 2025.
Outlook and guidance
Organic growth for 2025 expected to exceed 2024; operating margin guidance maintained at around 13% at constant scope.
Order book at quarter-end is encouraging and consistent with previous years, supporting confidence in gradual improvement through the year.
BVA acquisition expected to close by late June, with integration to restore margins to group average within 18-24 months.
Latest events from Ipsos
- 2025 revenue rose 3.4% with resilient margins and digital gains, setting up for higher growth.IPS
Q4 202525 Feb 2026 - GenAI, digitalization, and targeted M&A accelerate growth, margin, and innovation.IPS
Investor Day 202413 Feb 2026 - Revenue up 4.7% with margin gains, digital growth, and US headwinds; outlook trimmed.IPS
Q2 20243 Feb 2026 - AI-powered transformation and global expansion target 5%+ growth and 8% EPS gains by 2030.IPS
Investor Day 202622 Jan 2026 - Q3 revenue up 0.5%, 2024 organic growth forecast cut to 1%, margin target held at 13%.IPS
Q3 202418 Jan 2026 - Record gross margin and strong cash flow in 2024; EMEA growth offset US decline.IPS
Q4 202418 Dec 2025 - H1 2025 saw 1.5% growth, tech-driven gains, and margin pressure from acquisitions.IPS
Q2 202516 Nov 2025 - Q3 organic growth rebounded to 2.9%, but public sector weakness lowered 2025 guidance.IPS
Q3 202523 Oct 2025